OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
March 09, 2006
Eisai Plans $105 Million Pharma Production and Formulation R&D Facility
BMS Plans to Build $660 Million Bulk Biologics Manufacturing Facility
March 02, 2006
Facing still-sluggish market conditions and a changing world order in fine chemicals, the large Western custom manufacturers are responding by building their toolboxes in specialized technologies in chiral chemistry, catalysis, and biosciences and by adjusting their manufacturing networks via streamlining or investment in Asia.
P&G Pharmaceuticals Plans Job Cuts
Chiron and Novartis Advance Programs for Pandemic Flu
Chiron To Sell Betaseron Assets to Schering